You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LOMAIRA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LOMAIRA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03374956 ↗ Individualized Obesity Pharmacotherapy Active, not recruiting Mayo Clinic Phase 3 2017-12-11 The researchers are trying to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss.
NCT04095104 ↗ Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Recruiting National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 2020-01-15 The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total).
NCT04095104 ↗ Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Recruiting University of Colorado- Clinical and Translational Sciences Institute Phase 2 2020-01-15 The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total).
NCT04095104 ↗ Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Recruiting University of Colorado- Nutrition Obesity Research Center Phase 2 2020-01-15 The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total).
NCT04095104 ↗ Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds Recruiting Jaime Moore, MD MPH Phase 2 2020-01-15 The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total).
NCT04614545 ↗ Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity Active, not recruiting The Cleveland Clinic Phase 4 2021-01-01 This study will study the effects associated with the prescription of phentermine in a virtual setting, comparing with prescription of phentermine via a standard face-to-face visit for patients with obesity or overweight.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LOMAIRA

Condition Name

Condition Name for LOMAIRA
Intervention Trials
Obesity 3
Young Adult 1
Adolescent 1
Bariatric Surgery 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LOMAIRA
Intervention Trials
Obesity 4
Overweight 1
Obesity, Morbid 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LOMAIRA

Trials by Country

Trials by Country for LOMAIRA
Location Trials
United States 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LOMAIRA
Location Trials
Minnesota 2
Texas 1
North Carolina 1
Maryland 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LOMAIRA

Clinical Trial Phase

Clinical Trial Phase for LOMAIRA
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LOMAIRA
Clinical Trial Phase Trials
Active, not recruiting 2
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LOMAIRA

Sponsor Name

Sponsor Name for LOMAIRA
Sponsor Trials
University of Colorado- Nutrition Obesity Research Center 1
Wake Forest University Health Sciences 1
Jaime Moore, MD MPH 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LOMAIRA
Sponsor Trials
Other 13
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.